NL940011I1 - Gesubstitueerde (2-imidazolin-2-yl)aminopirimidinen alsmede farmaceutisch preparaat met antihypertensieve werking dat een of meer van deze verbindingen bevat - Google Patents
Gesubstitueerde (2-imidazolin-2-yl)aminopirimidinen alsmede farmaceutisch preparaat met antihypertensieve werking dat een of meer van deze verbindingen bevatInfo
- Publication number
- NL940011I1 NL940011I1 NL940011C NL940011C NL940011I1 NL 940011 I1 NL940011 I1 NL 940011I1 NL 940011 C NL940011 C NL 940011C NL 940011 C NL940011 C NL 940011C NL 940011 I1 NL940011 I1 NL 940011I1
- Authority
- NL
- Netherlands
- Prior art keywords
- aminopirimidines
- imidazolin
- substituted
- compounds
- well
- Prior art date
Links
- -1 2-imidazolin-2-yl Chemical group 0.000 title 1
- 230000003276 anti-hypertensive effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2849537A DE2849537C2 (de) | 1978-11-15 | 1978-11-15 | Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE19792937023 DE2937023A1 (de) | 1979-09-13 | 1979-09-13 | Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL940011I1 true NL940011I1 (nl) | 1994-08-01 |
| NL940011I2 NL940011I2 (nl) | 1998-05-06 |
Family
ID=25776489
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7908192,A NL190553C (nl) | 1978-11-15 | 1979-11-08 | Gesubstitueerde (2-imidazolin-2-yl)aminopirimidinen, alsmede farmaceutisch preparaat met antihypertensieve werking, dat een of meer van deze verbindingen bevat. |
| NL940011C NL940011I2 (nl) | 1978-11-15 | 1994-06-27 | Gesubstitueerde (2-imidazolin-2-yl)aminopirimidinen, alsmede farmaceutisch preparaat met antihypertensieve werking, dat een of meer van deze verbindingen bevat. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7908192,A NL190553C (nl) | 1978-11-15 | 1979-11-08 | Gesubstitueerde (2-imidazolin-2-yl)aminopirimidinen, alsmede farmaceutisch preparaat met antihypertensieve werking, dat een of meer van deze verbindingen bevat. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4323570A (nl) |
| AT (1) | AT374197B (nl) |
| AU (1) | AU541305B1 (nl) |
| CA (1) | CA1138454A (nl) |
| CH (1) | CH642965A5 (nl) |
| DK (1) | DK150142C (nl) |
| ES (1) | ES486349A1 (nl) |
| FR (1) | FR2441625A1 (nl) |
| GB (1) | GB2039275B (nl) |
| IT (1) | IT1127225B (nl) |
| NL (2) | NL190553C (nl) |
| SE (1) | SE440079B (nl) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2146986B (en) * | 1983-09-23 | 1987-06-17 | Lilly Co Eli | Process for preparing 5-substituted pyrimidines |
| DE3729299A1 (de) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | Transdermales therapeutisches system |
| DE3739779A1 (de) * | 1987-11-24 | 1989-06-08 | Beiersdorf Ag | Pharmazeutische praeparate |
| DE3904795C2 (de) * | 1989-02-17 | 2000-10-12 | Lilly Pharma Produktion Gmbh & | Pharmazeutisches Präparat und dessen Verwendung |
| DE4423177A1 (de) * | 1994-07-01 | 1996-01-04 | Kali Chemie Pharma Gmbh | Antihyperglykämisch wirksame Arzneimittel |
| US5972948A (en) * | 1994-07-01 | 1999-10-26 | Solvay Pharmaceuticals Gmbh | Method of inhibiting hyperglycemia and pharmaceutical composition for use therein |
| US5977121A (en) * | 1995-02-28 | 1999-11-02 | Eli Lilly And Company | Use of moxonidine for the treatment of atherosclerosis |
| DE19514579A1 (de) * | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| IL118544A (en) * | 1995-06-07 | 2001-08-08 | Smithkline Beecham Corp | History of imidazole, the process for their preparation and the pharmaceutical preparations containing them |
| CA2182851A1 (en) * | 1995-08-15 | 1997-02-16 | August Masaru Watanabe | Method for treating substance abuse withdrawal |
| ZA974978B (en) * | 1996-06-06 | 1998-12-07 | Lilly Co Eli | Formulation and method for treating congestive heart failure |
| IL123232A0 (en) * | 1997-02-11 | 1999-11-30 | Lilly Co Eli | Medicament for inhibiting glucose metabolism deterioration |
| DE19722322A1 (de) * | 1997-05-28 | 1998-12-03 | Solvay Pharm Gmbh | Nephroprotektives Arzneimittel |
| AU9302298A (en) * | 1997-09-03 | 1999-03-22 | Eli Lilly And Company | Pyrimidine derivatives |
| DE19911371A1 (de) | 1999-03-15 | 2000-09-21 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen |
| AU2003257418A1 (en) * | 2002-06-19 | 2004-01-06 | Solvay Pharmaceuticals Gmbh | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
| AU2007213887A1 (en) * | 2006-01-27 | 2007-08-16 | F. Hoffmann-La Roche Ag | Use of 2-imidazoles for the treatment of CNS disorders |
| ATE520685T1 (de) * | 2006-06-26 | 2011-09-15 | Chemagis Ltd | Verbessertes verfahren zur herstellung von moxonidin |
| ATE411310T1 (de) * | 2006-06-26 | 2008-10-15 | Chemagis Ltd | Reinigungsverfahren von moxonidine |
| EP1894926A1 (en) * | 2006-06-26 | 2008-03-05 | Chemagis Ltd. | Polymorphs of moxonidine and processes for preparation therefor |
| WO2008020425A1 (en) * | 2006-08-17 | 2008-02-21 | Chemagis Ltd. | Crystalline moxonidine comprising single tautomer and preparation process therefor |
| EP1894927B1 (en) * | 2006-08-31 | 2010-11-10 | Chemagis Ltd. | The use of moxonidine salts for purification of moxonidine |
| KR101176699B1 (ko) * | 2006-10-19 | 2012-08-23 | 에프. 호프만-라 로슈 아게 | 아미노메틸-4-이미다졸 |
| KR101172940B1 (ko) * | 2006-10-19 | 2012-08-10 | 에프. 호프만-라 로슈 아게 | 트레이스 아민 관련 수용체에 대해 친화도를 갖는 아미노메틸-2-이미다졸 |
| ATE533755T1 (de) * | 2006-11-02 | 2011-12-15 | Hoffmann La Roche | Substituierte 2-imidazole als modulatoren der mit spurenaminen assoziierten rezeptoren |
| RU2456281C2 (ru) * | 2006-11-16 | 2012-07-20 | Ф. Хоффманн-Ля Рош Аг | Замещенные 4-имидазолы, способ их получения и их применение |
| WO2008073125A1 (en) * | 2006-12-12 | 2008-06-19 | Chemagis Ltd. | Moxonidine analogs, preparation processes and uses therefor |
| BRPI0720047A2 (pt) * | 2006-12-13 | 2013-12-24 | Hoffmann La Roche | 2-imidazóis como ligantes para receptores associados a aminas de traço (taar) |
| US20080146523A1 (en) * | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
| CA2675221C (en) * | 2007-02-02 | 2016-02-23 | F. Hoffmann-La Roche Ag | Novel 2-aminooxazolines as taar1 ligands |
| KR101222412B1 (ko) * | 2007-02-15 | 2013-01-15 | 에프. 호프만-라 로슈 아게 | Ｔａａｒ1 리간드로서의 2-아미노옥사졸린 |
| WO2009003868A2 (en) | 2007-07-02 | 2009-01-08 | F. Hoffmann-La Roche Ag | 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| CA2691704A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
| BRPI0813837A2 (pt) * | 2007-07-27 | 2015-01-06 | Hoffmann La Roche | 2-azetidinametanoaminas e 2-pirrolidinametanoaminas como ligantes de taar |
| WO2009016088A1 (en) * | 2007-08-02 | 2009-02-05 | F. Hoffmann-La Roche Ag | The use of benzamide derivatives for the treatment of cns disorders |
| JP5341084B2 (ja) * | 2007-08-03 | 2013-11-13 | エフ．ホフマン−ラ ロシュ アーゲー | Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体 |
| RU2513086C2 (ru) * | 2008-07-24 | 2014-04-20 | Ф.Хоффманн-Ля Рош Аг | Производные 4,5-дигидро-оксазол-2-ила |
| US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
| US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| EP2586779A1 (en) | 2011-10-24 | 2013-05-01 | Hetero Research Foundation | Process for the preparation of moxonidine |
| DE102012215896A1 (de) * | 2012-09-07 | 2014-03-13 | Wörwag Pharma GmbH & Co.KG | Moxonidinsynthese mit Hilfe organischer Basen |
| ES2608004T3 (es) | 2012-12-03 | 2017-04-05 | WÖRWAG PHARMA GmbH & Co. KG | Método mediante catálisis por transferencia de fase |
| EP2765131B1 (en) | 2013-02-08 | 2016-11-23 | Arevipharma GmbH | Process for the production of Moxonidine |
| CN105121431A (zh) * | 2013-03-14 | 2015-12-02 | 法尔马克有限公司 | 用于制造莫索尼定的改进方法 |
| EP2829540A1 (en) | 2013-07-26 | 2015-01-28 | Abbott Healthcare Products B.V. | Synthesis of substituted aminopyridines |
| WO2015021358A2 (en) | 2013-08-09 | 2015-02-12 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
| AU2017234042B2 (en) | 2016-03-17 | 2020-11-19 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR |
| JP2023549394A (ja) | 2020-11-12 | 2023-11-24 | スリールセータ エーハゥーエッフ | 注意欠陥／多動性障害の新規な治療 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754832A (fr) | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | Iminazolines |
| GB1319840A (en) * | 1970-08-27 | 1973-06-13 | Beecham Group Ltd | Substituted 5-amino imidazoles |
| BE795636A (fr) * | 1972-02-19 | 1973-08-20 | Schering Ag | Nitroimidazolylpyrimidines, et leur procede de preparation |
| US4029792A (en) * | 1972-02-29 | 1977-06-14 | Pfizer Inc. | (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents |
| DE2220906A1 (de) * | 1972-04-28 | 1973-11-15 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung |
| BE503170A (nl) * | 1975-09-02 |
-
1979
- 1979-11-07 US US06/092,134 patent/US4323570A/en not_active Expired - Lifetime
- 1979-11-08 NL NLAANVRAGE7908192,A patent/NL190553C/nl not_active IP Right Cessation
- 1979-11-14 IT IT27284/79A patent/IT1127225B/it active
- 1979-11-14 SE SE7909392A patent/SE440079B/sv not_active IP Right Cessation
- 1979-11-14 DK DK481879A patent/DK150142C/da not_active IP Right Cessation
- 1979-11-14 GB GB7939460A patent/GB2039275B/en not_active Expired
- 1979-11-14 CA CA000339844A patent/CA1138454A/en not_active Expired
- 1979-11-14 ES ES486349A patent/ES486349A1/es not_active Expired
- 1979-11-14 AT AT0727079A patent/AT374197B/de not_active IP Right Cessation
- 1979-11-15 FR FR7928169A patent/FR2441625A1/fr active Granted
- 1979-11-15 AU AU52873/79A patent/AU541305B1/en not_active Expired
- 1979-11-15 CH CH1021679A patent/CH642965A5/de not_active IP Right Cessation
-
1994
- 1994-06-27 NL NL940011C patent/NL940011I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7908192A (nl) | 1980-05-19 |
| ES486349A1 (es) | 1980-06-16 |
| DK150142C (da) | 1987-06-01 |
| ATA727079A (de) | 1983-08-15 |
| FR2441625A1 (fr) | 1980-06-13 |
| AT374197B (de) | 1984-03-26 |
| NL940011I2 (nl) | 1998-05-06 |
| SE440079B (sv) | 1985-07-15 |
| GB2039275B (en) | 1982-11-17 |
| US4323570A (en) | 1982-04-06 |
| FR2441625B1 (nl) | 1981-12-31 |
| CA1138454A (en) | 1982-12-28 |
| NL190553B (nl) | 1993-11-16 |
| SE7909392L (sv) | 1980-05-16 |
| IT1127225B (it) | 1986-05-21 |
| IT7927284A0 (it) | 1979-11-14 |
| AU541305B1 (en) | 1985-01-03 |
| NL190553C (nl) | 1994-04-18 |
| DK150142B (da) | 1986-12-15 |
| GB2039275A (en) | 1980-08-06 |
| DK481879A (da) | 1980-05-16 |
| CH642965A5 (de) | 1984-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL940011I1 (nl) | Gesubstitueerde (2-imidazolin-2-yl)aminopirimidinen alsmede farmaceutisch preparaat met antihypertensieve werking dat een of meer van deze verbindingen bevat | |
| NL193457B (nl) | Benzoheterocyclische verbindingen en farmaceutisch preparaat dat een dergelijke verbinding bevat. | |
| IT1113721B (it) | Additivo per materiali da costuzione | |
| SE7907663L (sv) | Bentonitkomposition | |
| IT1235758B (it) | Composti aril-ciclobutil-amminici sostituiti, procedimenti per prepararli, composti intermedi e composizioni farmaceutiche che li contengono | |
| IT1062551B (it) | Composto di molibideno diidrocarbil-ditiocarbamato contenente zolfo | |
| IT7928464A0 (it) | Composizione farmaceutica avente attivita' antitumorale. | |
| FI822683L (fi) | Inert fyllnadsmaterial foer farmaceutiska kompositioner | |
| BE879263A (fr) | Compose de 2-methyl-dihydropyridine, procedes pour son obtention et composition pharmaceutique contenant ce compose | |
| IT7949422A0 (it) | Composizione tensioattiva di alcossi-bis(trialcossi-silossi)-silano | |
| NL194203B (nl) | 1,4-dihydropyridineverbindingen en farmaceutisch preparaat dat ÚÚn of meer van deze bevat. | |
| NL190662C (nl) | alfa-Halogeenmethyl-alfa-aminozuurderivaten en farmaceutisch preparaat dat dit bevat. | |
| IT1193847B (it) | Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline | |
| FI792319A (fi) | Guargum innehaollande farmaceutisk komposition | |
| NL190485C (nl) | alfa-Fluormethyl-alfa-aminoalkaanzuurderivaat, farmaceutisch preparaat dat één of meer zodanige verbindingen bevat, alsmede werkwijze voor het bereiden van de verbindingen. | |
| IT7949064A0 (it) | Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina | |
| IT1124841B (it) | Composti contenenti zolfo anti-ipertensione | |
| DK461579A (da) | Farmeceutisk komposition indeholdende en aryltrifluorethanol | |
| RO79037A (ro) | Compozitie fungicida | |
| IL58576A0 (en) | 2-substituted and 2,6 disubstituted penem compounds their preparation and pharmaceutical compositions containing them | |
| JPS54122265A (en) | Organic compound*its manufacture and pharmaceutical composition containing it | |
| IT8148776A0 (it) | Composti eterociclici loro preparazione e composizione farmaceutiche contenenti questi composti | |
| FI790152A (fi) | Hydraulisk komposition | |
| NL187168C (nl) | 3 beta-oxygesubstitueerde-18 beta-olean-30-carboxyderivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten welke een of meer van deze verbindingen bevatten. | |
| NL7812144A (nl) | 3-di-n-propyl-acetoxy-benzodiazepin-2-on-verbindingen, werkwijze voor de bereiding daarvan; spasmolytisch preparaat, dat een of meer van dergelijke verbindingen bevat. |